What We Do
New Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions specifically oxidative stress (ROS) driven inflammation, with an initial focus on Covid-19 Variants and CNS Disorders.
Progressive Supranuclear Palsy
Developing first-in-line therapies for orphan neurodegenerative disorders like Progressive Supranuclear Palsy (PSP).Influenza
Developing targeted therapies and adjuvants for influenza which have demonstrated greater efficacy than Tamiflu, the current “gold standard.”Radiomitigators
Developing radiation mitigators to treat the difficult side effects that can occur from undergoing radiation therapy for cancer, as well as biodefense applications.Narrow focus, open minds
Through the company's anti-inflammatory platform and it's family of therapeutics, NAS pursues novel treatments to enhance the lives of patients in multiple areas of development. Other Areas of InterestCovid Hot Spots
© 2020 New Amsterdam Sciences | Terms of Use | Privacy Policy | Contact Us